X-124371389-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_002351.5(SH2D1A):c.385T>G(p.Ter129Glyext*?) variant causes a stop lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002351.5 stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome Cov.: 22
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
X-linked lymphoproliferative disease due to SH2D1A deficiency Uncertain:1
This variant is not present in population databases (gnomAD no frequency). This sequence change disrupts the translational stop signal of the SH2D1A mRNA. It is expected to extend the length of the SH2D1A protein by 12 additional amino acid residues. This variant has not been reported in the literature in individuals affected with SH2D1A-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant results in an extension of the SH2D1A protein. Other variant(s) that result in a similarly extended protein product (p.*129Argext*12) have been observed in individuals with SH2D1A-related disease (PMID: 18055393, 19937601, 21815800, 29604111). This suggests that these extensions may be clinically significant. ClinVar contains an entry for this variant (Variation ID: 1471227). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.